These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 38288568)

  • 41. Specialized
    Li D; Lu HT; Ding YZ; Wang HJ; Ye JL; Qin CF; Liu ZY
    J Virol; 2023 Apr; 97(4):e0194922. PubMed ID: 37017533
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Thiosemicarbazones and Phthalyl-Thiazoles compounds exert antiviral activity against yellow fever virus and Saint Louis encephalitis virus.
    Pacca CC; Marques RE; Espindola JWP; Filho GBOO; Leite ACL; Teixeira MM; Nogueira ML
    Biomed Pharmacother; 2017 Mar; 87():381-387. PubMed ID: 28068627
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Molecular and immunological characterization of a DNA-launched yellow fever virus 17D infectious clone.
    Jiang X; Dalebout TJ; Lukashevich IS; Bredenbeek PJ; Franco D
    J Gen Virol; 2015 Apr; 96(Pt 4):804-814. PubMed ID: 25516543
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Yellow Fever: Integrating Current Knowledge with Technological Innovations to Identify Strategies for Controlling a Re-Emerging Virus.
    Kleinert RDV; Montoya-Diaz E; Khera T; Welsch K; Tegtmeyer B; Hoehl S; Ciesek S; Brown RJP
    Viruses; 2019 Oct; 11(10):. PubMed ID: 31627415
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical evidence for the immunogenicity and immune persistence of vaccination with yellow fever virus strain 17D in Chinese peacekeepers deployed to Africa.
    Jia Q; Jia C; Liu Y; Yang Y; Qi J; Tong L; Chen H; Zhang M; Che J; Li B; Li Z
    Antiviral Res; 2019 Feb; 162():1-4. PubMed ID: 30529359
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Broad-Spectrum Antiviral Activity of Influenza A Defective Interfering Particles against Respiratory Syncytial, Yellow Fever, and Zika Virus Replication In Vitro.
    Pelz L; Piagnani E; Marsall P; Wynserski N; Hein MD; Marichal-Gallardo P; Kupke SY; Reichl U
    Viruses; 2023 Sep; 15(9):. PubMed ID: 37766278
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Transmission of yellow fever vaccine virus from breast feeding mothers to their infants: reporting of yellow fever virus (YFV) RNA detection in milk specimens.
    Hassan T; Bashir RA; Abdelrahman DN; Madni H; M El Hussein AR; Elkidir IM; Enan KA
    F1000Res; 2022; 11():76. PubMed ID: 38106444
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MEK/ERK activation plays a decisive role in yellow fever virus replication: implication as an antiviral therapeutic target.
    Albarnaz JD; De Oliveira LC; Torres AA; Palhares RM; Casteluber MC; Rodrigues CM; Cardozo PL; De Souza AM; Pacca CC; Ferreira PC; Kroon EG; Nogueira ML; Bonjardim CA
    Antiviral Res; 2014 Nov; 111():82-92. PubMed ID: 25241249
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection
    Douam F; Soto Albrecht YE; Hrebikova G; Sadimin E; Davidson C; Kotenko SV; Ploss A
    mBio; 2017 Aug; 8(4):. PubMed ID: 28811340
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Synthetic strategy and antiviral evaluation of diamide containing heterocycles targeting dengue and yellow fever virus.
    Saudi M; Zmurko J; Kaptein S; Rozenski J; Gadakh B; Chaltin P; Marchand A; Neyts J; Van Aerschot A
    Eur J Med Chem; 2016 Oct; 121():158-168. PubMed ID: 27240271
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Generation of a reporter yellow fever virus for high throughput antiviral assays.
    Sanchez-Velazquez R; de Lorenzo G; Tandavanitj R; Setthapramote C; Bredenbeek PJ; Bozzacco L; MacDonald MR; Clark JJ; Rice CM; Patel AH; Kohl A; Varjak M
    Antiviral Res; 2020 Nov; 183():104939. PubMed ID: 32980446
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-respiratory syncytial virus and anti-herpes simplex virus activity of six Tanzanian medicinal plants with extended studies of Erythrina abyssinica stem bark.
    Mollel JT; Said JS; Masalu RJ; Hannoun C; Mbunde MVN; Nondo RSO; Bergström T; Trybala E
    J Ethnopharmacol; 2022 Jun; 292():115204. PubMed ID: 35304278
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of a Bicistronic Yellow Fever Live Attenuated Vaccine with Reduced Neurovirulence and Viscerotropism.
    Wang HJ; Guo Y; He MJ; Liu ZY; Ye Q; Huang XY; Deng YQ; Li XF; Qin CF
    Microbiol Spectr; 2022 Oct; 10(5):e0224622. PubMed ID: 35980184
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Remdesivir efficacy against yellow fever in a hamster model.
    Julander JG; Bunyan E; Jordan R; Porter DP
    Antiviral Res; 2022 Jul; 203():105331. PubMed ID: 35533777
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine and Wild-Type Strains of Yellow Fever Virus Engage Distinct Entry Mechanisms and Differentially Stimulate Antiviral Immune Responses.
    Fernandez-Garcia MD; Meertens L; Chazal M; Hafirassou ML; Dejarnac O; Zamborlini A; Despres P; Sauvonnet N; Arenzana-Seisdedos F; Jouvenet N; Amara A
    mBio; 2016 Feb; 7(1):e01956-15. PubMed ID: 26861019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Antiviral and cytotoxic activities of aminoarylazo compounds and aryltriazene derivatives.
    Tonelli M; Vazzana I; Tasso B; Boido V; Sparatore F; Fermeglia M; Paneni MS; Posocco P; Pricl S; La Colla P; Ibba C; Secci B; Collu G; Loddo R
    Bioorg Med Chem; 2009 Jul; 17(13):4425-40. PubMed ID: 19482481
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacological Characterization of TP0591816, a Novel Macrocyclic Respiratory Syncytial Virus Fusion Inhibitor with Antiviral Activity against F Protein Mutants.
    Yoshida I; Arikawa K; Honma Y; Inatani S; Yoshinaga M; Sugiyama H
    Antimicrob Agents Chemother; 2020 Dec; 65(1):. PubMed ID: 33046486
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sero-prevalence of yellow fever and related Flavi viruses in Ethiopia: a public health perspective.
    Mengesha Tsegaye M; Beyene B; Ayele W; Abebe A; Tareke I; Sall A; Yactayo S; Shibeshi ME; Staples E; Belay D; Lilay A; Alemu A; Alemu E; Kume A; H/Mariam A; Ronveaux O; Tefera M; Kassa W; Bekele Weyessa A; Jima D; Kebede A; Tayachew A
    BMC Public Health; 2018 Aug; 18(1):1011. PubMed ID: 30107830
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation and Kinetics of Circulating T Follicular Helper Cells, Specific Plasmablast Response, and Development of Neutralizing Antibodies following Yellow Fever Virus Vaccination.
    Sandberg JT; Ols S; Löfling M; Varnaitė R; Lindgren G; Nilsson O; Rombo L; Kalén M; Loré K; Blom K; Ljunggren HG
    J Immunol; 2021 Aug; 207(4):1033-1043. PubMed ID: 34321231
    [TBL] [Abstract][Full Text] [Related]  

  • 60. A yellow fever virus NS4B inhibitor not only suppresses viral replication, but also enhances the virus activation of RIG-I-like receptor-mediated innate immune response.
    Gao Z; Zhang X; Zhang L; Wu S; Ma J; Wang F; Zhou Y; Dai X; Bullitt E; Du Y; Guo JT; Chang J
    PLoS Pathog; 2022 Jan; 18(1):e1010271. PubMed ID: 35061864
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.